date
still
varieti
human
diseas
unknown
etiolog
viral
origin
suggest
mani
diseas
emphas
import
continu
search
new
major
difficulti
encount
howev
search
new
virus
first
virus
replic
vitro
least
cell
commonli
use
viral
diagnost
second
virus
replic
vitro
caus
cytopath
effect
cpe
subsequ
viru
identif
method
may
fail
antibodi
rais
known
virus
may
recogn
cultur
viru
virusspecif
pcr
method
may
amplifi
new
viral
genom
solv
problem
develop
new
method
viru
discoveri
base
cdnaamplifi
restrict
polymorph
techniqu
report
identif
new
coronaviru
use
method
virusdiscoverycdnaaflp
vidisca
coronavirus
genu
coronavirida
famili
envelop
virus
larg
plusstrand
rna
genom
genom
rna
kb
size
cap
polyadenyl
three
serolog
distinct
group
coronavirus
describ
within
group
virus
character
host
rang
genom
sequenc
coronavirus
identifi
mice
rat
chicken
turkey
swine
dog
cat
rabbit
hors
cattl
human
caus
varieti
sever
diseas
includ
gastroenter
respiratori
tract
three
human
coronavirus
studi
detail
identifi
known
caus
common
recent
identifi
sarscov
caus
lifethreaten
pneumonia
pathogen
human
coronaviru
identifi
thu
sarscov
like
resid
anim
reservoir
recent
initi
epidem
human
zoonot
suggest
sarscov
first
member
fourth
group
coronavirus
outlier
group
ref
new
coronaviru
present
isol
child
suffer
bronchiol
conjunct
isol
case
identifi
viru
clinic
specimen
seven
addit
individu
infant
adult
last
winter
season
also
resolv
complet
sequenc
viral
genom
reveal
sever
uniqu
featur
januari
child
admit
hospit
coryza
conjunct
fever
chest
radiographi
reveal
typic
featur
bronchiol
nasopharyng
aspir
specimen
collect
onset
diseas
sampl
diagnost
test
respiratori
syncyti
viru
adenoviru
influenza
virus
b
parainfluenza
viru
type
rhinoviru
enteroviru
yield
neg
result
clinic
sampl
subsequ
inocul
onto
human
fetal
lung
fibroblast
tertiari
monkey
kidney
cell
cynomolgu
monkey
hela
cell
cpe
detect
exclus
tertiari
monkey
kidney
cell
first
note
inocul
cpe
diffus
refract
appear
affect
cell
follow
cell
detach
pronounc
cpe
observ
upon
passag
onto
monkey
kidney
cell
line
overal
cell
round
moder
cell
enlarg
supplementari
fig
onlin
addit
subcultur
human
fetal
lung
fibroblast
rhabdomyosarcoma
cell
vero
cell
remain
neg
cpe
immunofluoresc
assay
detect
respiratori
syncyti
viru
adenoviru
influenza
virus
b
parainfluenza
viru
type
remain
neg
acid
labil
chloroform
sensit
test
indic
viru
like
envelop
belong
picornaviru
identif
unknown
pathogen
use
molecular
biolog
tool
difficult
target
sequenc
known
genomespecif
pcr
primer
design
overcom
problem
develop
vidisca
method
base
cdnaaflp
advantag
vidisca
prior
knowledg
sequenc
requir
presenc
restrict
enzym
site
suffici
guarante
pcr
amplif
input
sampl
either
blood
plasma
serum
cultur
supernat
wherea
cdnaaflp
start
isol
mrna
vidisca
begin
treatment
select
enrich
viral
nucleic
acid
includ
centrifug
step
remov
residu
cell
mitochondria
fig
dnase
treatment
also
use
remov
interf
chromosom
mitochondri
dna
degrad
cell
viral
nucleic
acid
protect
within
viral
particl
final
choos
frequent
cut
restrict
enzym
method
finetun
virus
amplifi
abl
amplifi
viral
nucleic
acid
edtatr
plasma
person
hepat
b
viral
infect
person
acut
parvoviru
infect
fig
techniqu
also
detect
cell
cultur
demonstr
capac
identifi
rna
dna
virus
fig
supernat
cpeposit
cultur
analyz
vidisca
supernat
uninfect
cell
use
neg
control
second
pcr
amplif
step
uniqu
promin
dna
fragment
present
test
sampl
control
select
pcr
reaction
shown
fig
fragment
clone
sequenc
thirteen
fragment
show
sequenc
similar
member
coronaviru
famili
signific
sequenc
diverg
known
coronavirus
appar
fragment
indic
identifi
new
coronaviru
sequenc
vidisca
fragment
provid
supplementari
figur
onlin
show
origin
nasopharyng
aspir
child
design
diagnost
rtpcr
specif
detect
test
confirm
presenc
clinic
sampl
sequenc
rtpcr
product
gene
ident
viru
identifi
upon
vitro
passag
cell
data
shown
confirm
cultur
coronaviru
origin
child
question
remain
whether
isol
clinic
case
whether
circul
human
address
question
use
two
diagnost
rtpcr
assay
examin
respiratori
specimen
hospit
individu
visit
outpati
clinic
decemb
august
fig
identifi
seven
addit
individu
carri
tabl
sequenc
analysi
pcr
product
indic
presenc
characterist
point
mutat
sever
sampl
suggest
sever
virus
differ
molecular
marker
may
cocircul
fig
supplementari
fig
onlin
least
five
individu
suffer
respiratori
tract
ill
clinic
data
two
individu
avail
includ
index
case
five
patient
children
less
year
old
three
patient
adult
two
adult
like
immunosuppress
one
bone
marrow
transplant
recipi
hivposit
patient
suffer
aid
low
cell
count
tabl
clinic
data
avail
third
adult
one
patient
coinfect
respiratori
syncyti
viru
hivinfect
patient
carri
pneumocysti
carinii
respiratori
agent
found
patient
suggest
respiratori
symptom
caus
posit
sampl
collect
last
winter
season
detect
frequenc
januari
none
sampl
collect
spring
summer
contain
p
twotail
test
genom
coronavirus
characterist
organ
twothird
contain
gene
encod
nonstructur
polyprotein
follow
gene
encod
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
genom
known
coronavirus
contain
variabl
number
uniqu
characterist
open
read
frame
orf
encod
nonstructur
protein
either
gene
e
gene
n
gene
downstream
n
gene
determin
whether
genom
organ
share
characterist
construct
cdna
librari
purifi
viru
stock
input
materi
total
genom
fragment
analyz
averag
coverag
seven
sequenc
per
nucleotid
specif
pcr
reaction
design
fill
gap
sequenc
region
lowqual
sequenc
data
combin
rapid
amplif
cdna
end
resolv
complet
genom
sequenc
rna
genom
consist
nucleotid
polya
tail
gc
content
lowest
gc
content
among
coronavirida
rang
ref
zcurv
softwar
use
identifi
genom
configur
portray
use
similar
known
coronavirus
guid
fig
supplementari
tabl
onlin
short
untransl
region
utr
nucleotid
present
termini
respect
gene
encod
rna
polymeras
proteas
essenti
viru
replic
potenti
pseudoknot
structur
present
posit
data
shown
may
provid
frameshift
signal
translat
polyprotein
gene
predict
encod
e
n
protein
found
part
genom
hemagglutininesteras
gene
present
group
coronavirus
present
locat
e
gene
probabl
encod
singl
accessori
nonstructur
protein
gene
show
limit
similar
porcin
epidem
diarrhea
viru
pedv
polyprotein
translat
genom
rna
remain
viral
protein
translat
subgenom
mrna
made
discontinu
transcript
neg
strand
subgenom
mrna
common
end
deriv
portion
genom
leader
sequenc
common
cotermin
part
discontinu
transcript
requir
basepair
cisact
transcript
regulatori
sequenc
trss
one
locat
near
part
viral
genom
leader
tr
other
locat
upstream
respect
orf
bodi
trss
cdna
bank
sequenc
contain
copi
subgenom
mrna
n
protein
thu
provid
opportun
exactli
map
leader
sequenc
fuse
subgenom
mrna
leader
nucleotid
identifi
utr
eleven
twelv
nucleotid
leader
tr
show
similar
bodi
tr
upstream
n
gene
put
trss
also
identifi
upstream
e
gene
supplementari
tabl
onlin
next
align
sequenc
complet
genom
coronavirus
percentag
nucleotid
ident
determin
gene
list
tabl
gene
except
gene
share
highest
ident
confirm
new
member
group
coronavirus
conduct
phylogenet
analysi
use
nucleotid
sequenc
n
gene
fig
gene
analyz
cluster
group
coronavirus
gene
close
relat
howev
inspect
reveal
subclust
pedv
phylogenet
analysi
could
perform
e
gene
region
variabl
small
analysi
respect
bootscan
analysi
simplot
softwar
version
ref
found
sign
recombin
data
shown
presenc
singl
nonstructur
gene
e
gene
noteworthi
almost
coronavirus
two
orf
region
except
pedv
ref
perhap
notabl
larg
insert
nucleotid
portion
gene
compar
blast
search
found
similar
addit
acid
domain
protein
coronaviru
sequenc
deposit
genbank
align
protein
sequenc
group
coronavirus
shown
supplementari
figur
onlin
studi
present
detail
descript
new
human
coronaviru
thu
far
three
human
coronavirus
character
includ
sarscov
character
fourth
member
provid
import
insight
variat
among
human
coronavirus
member
group
coronavirus
close
relat
differ
promin
first
share
averag
sequenc
ident
second
singl
gene
take
place
gene
third
region
gene
contain
larg
infram
insert
nucleotid
ntermin
region
protein
implic
bind
aminopeptidas
n
group
coronavirus
sialic
acid
insert
might
involv
receptor
bind
may
explain
tropism
viru
cell
cultur
howev
aminopeptidas
n
receptorbind
domain
protein
map
amino
acid
ref
seem
unlik
insert
directli
involv
bind
aminopeptidas
n
fourth
wherea
fastidi
cell
cultur
narrow
host
rang
replic
effici
monkey
kidney
cell
sarscov
also
abl
replic
monkey
kidney
cell
yet
predict
protein
sarscov
share
domain
could
explain
vitro
host
cell
rang
virus
viral
protein
may
influenc
cell
tropism
viru
none
protein
close
relat
sarscov
variabl
end
gene
correl
alter
tropism
also
describ
group
coronavirus
porcin
respiratori
coronaviru
prcov
transmiss
gastroenter
viru
tgev
porcin
virus
antigen
genet
relat
pathogen
markedli
differ
tgev
replic
destroy
enterocyt
small
intestin
caus
sever
diarrhea
high
mortal
neonat
swine
contrast
prcov
emerg
recent
tgev
select
tropism
respiratori
tissu
littl
capac
replic
intestin
tissu
differ
tgev
prcov
gene
sequenc
compar
differ
compar
tgev
prcov
contain
delet
hypervari
region
gene
extra
region
present
end
tgev
gene
respons
hemagglutin
activ
tgev
capac
bind
sialic
howev
region
show
similar
insert
common
viru
caus
seriou
respiratori
diseas
infant
immunocompromis
data
indic
caus
acut
respiratori
diseas
children
age
year
immunocompromis
adult
date
known
viral
pathogen
identifi
substanti
portion
respiratori
diseas
case
human
ref
sever
assay
use
diagnos
coronaviru
infect
tradit
antibodi
test
implement
measur
rise
titer
antibodi
human
coronavirus
ref
antibodi
might
crossreact
given
virus
member
serotyp
case
infect
might
misdiagnos
molecular
biolog
tool
rtpcr
design
select
detect
human
coronavirus
assay
detect
even
rtpcr
assay
design
amplifi
known
abl
amplifi
sever
mismatch
primer
sequenc
avail
complet
genom
sequenc
mean
diagnost
assay
substanti
improv
result
indic
present
signific
number
respiratori
tract
ill
unknown
etiolog
detect
patient
suffer
respiratori
diseas
frequenc
januari
viru
detect
recent
sampl
collect
spring
summer
correl
fact
human
coronavirus
tend
transmit
predominantli
winter
futur
experi
sensit
diagnost
tool
yield
accur
pictur
preval
viru
associ
respiratori
diseas
viru
cultur
cell
detail
viru
cultur
patient
descript
avail
supplementari
method
onlin
remov
residu
cell
mitochondria
viru
cultur
supernat
spun
min
maximum
speed
rpm
eppendorf
microcentrifug
remov
chromosom
dna
mitochondri
dna
lyse
cell
supernat
transfer
fresh
tube
treat
dnase
min
ambion
nucleic
acid
extract
revers
transcript
reaction
perform
random
hexam
primer
amersham
bioscienc
moloney
murin
leukemia
viru
revers
transcriptas
mmlvrt
invitrogen
secondstrand
dna
synthesi
carri
sequenas
ii
amersham
bioscienc
without
addit
primer
phenolchloroform
extract
follow
ethanol
precipit
cdnaaflp
perform
essenti
modif
doublestrand
dna
digest
msei
restrict
enzym
new
england
biolab
msei
anchor
see
subsequ
ad
along
ligas
enzym
invitrogen
suppli
ligas
buffer
h
msei
anchor
prepar
mix
topstrand
oligonucleotid
msei
anchor
anchor
bottomstrand
oligonucleotid
msei
anchor
anchor
dilut
ligas
buffer
twenti
cycl
pcr
carri
ligat
mixtur
ng
standard
primer
ng
msei
standard
primer
five
microlit
pcr
product
use
input
second
select
amplif
step
along
ng
nprimer
ng
msei
nprimer
n
indic
standard
primer
extend
one
nucleotid
g
c
select
round
amplif
done
use
touchdown
pcr
cycl
min
anneal
temperatur
reduc
per
cycl
cycl
min
final
cycl
min
sixteen
pcr
reaction
primer
combin
conduct
sampl
select
pcr
pcr
product
analyz
metaphor
agaros
gel
cambrex
fragment
interest
clone
sequenc
use
bigdy
termin
reagent
electrophoresi
data
collect
perform
use
abi
instrument
dna
molecular
weight
marker
invitrogen
eurogentec
detect
use
vidisca
ecori
digest
instead
digest
vidisca
modifi
parvoviru
detect
follow
revers
transcript
step
exclud
digest
adaptor
ligat
perform
first
pcr
reaction
perform
cycl
instead
first
pcr
fragment
visual
agaros
gel
electrophoresi
detail
cdna
librari
construct
full
genom
sequenc
avail
supplementari
method
onlin
total
respiratori
sampl
collect
individu
decemb
august
academ
medic
center
amsterdam
specimen
includ
oral
nasopharyng
aspir
throat
swab
bronchoalveolar
lavag
sputum
sampl
collect
routin
viral
diagnost
screen
peopl
suffer
upper
andor
lower
respiratori
tract
diseas
patient
consent
sampl
use
test
respiratori
virus
includ
coronavirus
use
sampl
boom
diagnost
assay
design
base
sequenc
gene
revers
transcript
perform
mmlvrt
invitrogen
use
ng
revers
transcript
primer
repszrt
coordin
entir
revers
transcript
mixtur
ad
first
pcr
mixtur
contain
ng
primer
coordin
ng
primer
coordin
pcr
reaction
consist
follow
step
min
cycl
min
min
min
min
nest
pcr
start
use
first
pcr
product
ng
primer
coordin
ng
primer
coordin
twentyf
pcr
cycl
perform
use
profil
first
pcr
ten
microlit
pcr
product
analyz
agaros
gel
electrophoresi
posit
sampl
repeat
sequenc
confirm
presenc
verifi
neg
posit
pcr
result
addit
diagnost
rtpcr
assay
conduct
use
gene
primer
revers
transcriptas
primer
coordin
ss
coordin
coordin
first
pcr
coordin
ss
coordin
nest
pcr
detail
sequenc
analysi
avail
supplementari
method
onlin
sequenc
deposit
genbank
access
number
note
supplementari
inform
avail
natur
medicin
websit
